VUB and VIB launch new Bio Incubator Brussels on VUB campus
Catalyst for collaboration and biotechnological innovation
December 5, 2024
Innovating in the world of oncology through RNA therapeutics
December 3, 2024
ExeVir Announces Michael Garrett as New Chief Executive Officer
Company developing antibody therapeutics against emerging viral threats
November 18, 2024
Zymofix secures €2 million to scale microbial solutions for sustainable agriculture and beyond
• Additional financing to advance proprietary fermentation technology • Looking to expand the team to support its rapid growth • Rebranded from N-Fix to Zymofix – learn more at Zymofix.com
November 12, 2024
European Soy Industry Gathered in Ghent, Belgium during most Northern Soy Field Event
Protealis Hosted First Soy Field Day Event in Belgium to Highlight Innovations in Northern European Soy Cultivation
September 12, 2024
MRM Health, a VIB spin-off company, appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors
Ghent, Belgium, September 10, 2024 – MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today announced the appointment of Grégoire Franoux, M.B.A., to the newly created role of Chief Business Officer. Concurrently, the company has strengthened its Board of Directors with the appointment of industry veteran Ron Robison, M.D.
September 10, 2024